The European Commission has refused to publish full contracts with pharma giants to purchase billions of doses of Covid-19 vaccines. Now the EU’s top court is set to force its hand.
Because transparency rules are weak, it remains difficult to tell what €577bn in Covid-spending has achieved and who ultimately received it.
The EU’s €650bn pandemic era fund remains wide open to fraud with weak accountability and oversight, according to financial watchdogs
Financial watchdogs sitting in the European Parliament have cast serious doubt on the integrity of the EU’s Covid recovery fund — and threatened court action over its lack of transparency.